• 1
    Van Ness PC. Frontal and parietal lobe epilepsy. In: WyllieE, ed. The treatment of the epilepsies. Philadelphia : Lea & Febinger, 1993: 52532.
  • 2
    Armon C, Radtke RA, Friedman AH, et al. Predictors of outcome of epilepsy surgery: multivariate analysis with validation. Epilepsia 1996;37: 81421.
  • 3
    Engel J. Surgery for seizures. N Engl J Med 1996;334: 64752.
  • 4
    Duchowny M, Jayakar P, Resnick T, et al. Epilepsy surgery in the first three years of life. Epilepsia 1998;39: 73743.
  • 5
    Schiller Y, Cascino GD, Sharbrough FW. Chronic intracranial EEG monitoring for localizing the epileptogenic zone: an electroclinical correlation. Epilepsia 1998;39: 13028.
  • 6
    Holland KD, Wyllie E. Outcome after surgical treatment. Neurosurg Clin North Am 2002;13: 13544.
  • 7
    Wyler AR, Hermann BP, Richey ET. Results of reoperation for failed epilepsy surgery. J Neurosurg 1989;71: 8159.
  • 8
    Awad IA, Nayel MH, Luders H. Second operation after the failure of previous resection for epilepsy. Neurosurgery 1991;28: 5108.
  • 9
    Germano IM, Poulin N, Olivier A. Reoperation for recurrent temporal lobe epilepsy. J Neurosurg 1994;81: 316.
  • 10
    Salanova V, Quesney LF, Rasmussen T, et al. Reevaluation of surgical failures and the role of reoperation in 39 patients with frontal lobe epilepsy. Epilepsia 1994;35: 7080.
  • 11
    Shaver EG, Harvey AS, Morrison G, et al. Results and complications after reoperation for failed epilepsy surgery in children. Pediatr Neurosurg 1997;27: 194202.
  • 12
    Holmes MD, Wilensky AJ, Ojemann LM, et al. Predicting outcome following reoperation for medically intractable epilepsy. Seizure 1999;8: 1036.
  • 13
    Schwartz TH, Spencer DD. Strategies for reoperation after comprehensive epilepsy surgery. J Neurosurg 2001;95: 61523.
  • 14
    Viader F, Derlon JM, Petit-Taboue MC, et al. Recurrent oligodendroglioma diagnosed with 11C-l-methionine and PET: a case report. Eur Neurol 1993;33: 24851.
  • 15
    Chugani DC, Chugani HT, Muzik O, et al. Imaging epileptogenic tubers in children with tuberous sclerosis complex using alpha-[11C]methyl-l-tryptophan positron emission tomography. Ann Neurol 1998;44: 85866.
  • 16
    Fedi M, Reutens D, Okazawa H, et al. Localizing value of alpha-methyl-l-tryptophan PET in intractable epilepsy of neocortical origin. Neurology 2001;57: 162936.
  • 17
    Juhász C, Chugani DC, Muzik O, et al. Alpha-methyl-l-tryptophan PET detects epileptogenic cortex in children with intractable epilepsy. Neurology 2003;60: 9608.
  • 18
    Diksic M, Nagahiro S, Sourkes TL, et al. A new method to measure brain serotonin synthesis in vivo, I: theory and basic data for a biological model. J Cereb Blood Flow Metab 1990;10: 112.
  • 19
    Chugani DC, Heyes MP, Kuhn DM, et al. Evidence of α[11C]-methyl-l-tryptophan metabolism via the kynurenine pathway in tuberous sclerosis complex [Abstract]. Neuroscience 1998;24: 692.
  • 20
    Chugani DC, Muzik O. Alpha[C-11]methyl-l-tryptophan PET maps brain serotonin synthesis and kynurenine pathway metabolism. J Cereb Blood Flow Metab 2000;20: 29.
  • 21
    Asano E, Chugani DC, Muzik O, et al. Multimodality imaging for improved detection of epileptogenic foci in tuberous sclerosis complex. Neurology 2000;54: 197684.
  • 22
    Natsume J, Kumakura Y, Bernasconi N, et al. Alpha-[11C] methyl-l-tryptophan and glucose metabolism in patients with temporal lobe epilepsy. Neurology 2003;60: 75661.
  • 23
    Chugani DC, Muzik O, Chakraborty P, et al. Human brain serotonin synthesis capacity measured in vivo with alpha-[C-11]methyl-l-tryptophan. Synapse 1998;28: 3343.
  • 24
    Muzik O, Chugani DC, Shen C, et al. Noninvasive imaging of serotonin synthesis rate using PET and α-methyltryptophan in autistic children. In: CarsonRE, Daube-WitherspoonME, HerscovitchP, eds. Quantitative functional brain imaging with positron emission tomography. San Diego : Academic Press, 1998: 2016.
  • 25
    Muzik O, Chugani DC, Chenggang S, et al. Objective method for localization of cortical asymmetries using positron emission tomography to aid surgical resection of epileptic foci. Comput Aided Surg 1998;3: 7482.
  • 26
    Heyes MP, Markey SP. Quantification of quinolinic acid in rat brain, whole blood and plasma by gas chromatography and negative chemical ionization mass spectrometry: effects of systemic l-tryptophan administration on brain and blood quinolinic acid concentrations. Anal Biochem 1988;174: 34959.
  • 27
    Saito K, Crowley JS, Markey SP, et al. A mechanism for increased quinolinic acid formation following acute systemic immune stimulation. J Biol Chem 1993;268: 15496503.
  • 28
    Juhász C, Chugani DC, Heyes M, et al. Tryptophan metabolism in epileptogenic brain tumors: a PET study using alpha[C-11]methyl-l-tryptophan (AMT) [Abstract]. Neurology 2003;suppl 1: A67.
  • 29
    Heyes MP, Saito K, Major EO, et al. A mechanism of quinolinic acid formation by brain in inflammatory neurological disease: attenuation of synthesis from l-tryptophan by 6-chlorotryptophan and 4-chloro-3-hydroxyanthranilate. Brain 1993;116: 142550.
  • 30
    Saito K, Nowak TS Jr, Suyama K, et al. Kynurenine pathway enzymes in brain: responses to ischemic brain injury versus systemic immune activation. J Neurochem 1993;61: 206170.
  • 31
    Park K, Buchhalter J, McClelland R, et al. Frequency and significance of acute postoperative seizures following epilepsy surgery in children and adolescents. Epilepsia 2002;43: 87481.
  • 32
    Trottier S, Evrard B, Vignal JP, et al. The serotonergic innervation of the cerebral cortex in man and its changes in focal cortical dysplasia. Epilepsy Res 1996;25: 79106.
  • 33
    Toczek MT, Carson RE, Lang L, et al. PET imaging of 5-HT1A receptor binding in patients with temporal lobe epilepsy. Neurology 2003;60: 74956.
  • 34
    Agostino DM, Bastos A, Piras C, et al. Posterior quadrantic dysplasia: a surgical approach to a characteristic brain malformation [Abstract]. Neurology 2002;58(suppl 3):A52.